Citation 131059

ISODA,Y: NISHIZAWA,Y: YAMAGUCHI,S: HIRANO,J: YAMAMOTO,A: NUMATA,M:. (1993). ANTITUMOR ACTIVITY OF LIPIDS. ANTITUMOR ACTIVITY OF FREE FATTY ACIDS IN MICE WITH TRANSPLANTED TUMORS.. 42(11)

Citation Details

TitleANTITUMOR ACTIVITY OF LIPIDS. ANTITUMOR ACTIVITY OF FREE FATTY ACIDS IN MICE WITH TRANSPLANTED TUMORS.
AuthorsISODA,Y: NISHIZAWA,Y: YAMAGUCHI,S: HIRANO,J: YAMAMOTO,A: NUMATA,M:
Year1993
Volume42
Issue11

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
UNDEC-10-ENOIC ACID
INACTIVE
2
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PALMITOLEIC ACID
ACTIVE
3
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PALMITOELAIDIC ACID
ACTIVE
4
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PETROSELINIC ACID
STRONG ACTIVITY
5
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
OLEIC ACID
ACTIVE
6
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ELAIDIC ACID
ACTIVE
7
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
VACCENIC ACID,CIS:
ACTIVE
8
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
VACCENIC ACID,TRANS:
ACTIVE
9
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ERUCIC ACID
ACTIVE
10
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRASSIDIC ACID
ACTIVE
11
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LINOLEIC ACID
ACTIVE
12
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LINOELAIDIC ACID
ACTIVE
13
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LINOLENIC ACID,ALPHA:
ACTIVE
14
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LINOLENIC ACID,GAMMA:
ACTIVE
15
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ARACHIDONIC ACID
ACTIVE
16
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
EICOSAPENTA-17-ENOIC ACID
ACTIVE
17
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
DOCOSAHEXA-CIS-19-ENOIC ACID
ACTIVE
18
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
DEC-2-ENOIC ACID,10-HYDROXY:
ACTIVE
19
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PALMITIC ACID,2-HYDROXY:
ACTIVE
20
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
RICINOLEIC ACID
ACTIVE
21
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STEARIC ACID,9-10-DIHYDROXY:
STRONG ACTIVITY
22
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STEARIC ACID,HYDROXY-PHENYL:*
ACTIVE
23
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STEARIC ACID,ISO:
STRONG ACTIVITY
Show SPARQL Queries (1)